Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01986348
What this trial is testing

Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

Who this might be right for
GlioblastomaGlioma
Karyopharm Therapeutics Inc 76
Testing effectiveness (Phase 2)Ended earlyNCT00062504
What this trial is testing

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Teva Branded Pharmaceutical Products R&D, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00038493
What this trial is testing

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT07093814
What this trial is testing

VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

Who this might be right for
Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd. 42
Early research (Phase 1)Looking for participantsNCT05917145
What this trial is testing

ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

Who this might be right for
Glioblastoma
Mayo Clinic 94
Early research (Phase 1)Study completedNCT01435395
What this trial is testing

Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Emory University 12
Testing effectiveness (Phase 2)Study completedNCT00003466
What this trial is testing

Temozolomide in Treating Patients With Progressive Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 100
Testing effectiveness (Phase 2)Study completedNCT01817751
What this trial is testing

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
GlioblastomaRecurrent Adult Brain NeoplasmMalignant Glioma+1 more
Virginia Commonwealth University 47
Early research (Phase 1)Study completedNCT07635173
What this trial is testing

SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas

Who this might be right for
GliomaGlioblastomas (GBM)High Grade Gliomas
Shenzhen Zhenxing Medical Technology Co., Ltd 35
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Very early researchLooking for participantsNCT07268053
What this trial is testing

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

Who this might be right for
Glioblastoma (GBM)Brain Metastasases
Nader Sanai 15
Testing effectiveness (Phase 2)WithdrawnNCT01115036
What this trial is testing

A Panobinostat Presurgery

Who this might be right for
Recurrent Glioblastoma
Duke University
Testing effectiveness (Phase 2)Study completedNCT00870181
What this trial is testing

ADV-TK Improves Outcome of Recurrent High-Grade Glioma

Who this might be right for
Malignant Glioma of BrainGlioblastoma
Huazhong University of Science and Technology 47
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Not applicableStudy completedNCT02441322
What this trial is testing

Evaluating Therapeutic Response to Novo-TTF

Who this might be right for
Glioblastoma Multiforme
Abramson Cancer Center at Penn Medicine 30
Testing effectiveness (Phase 2)Ended earlyNCT02663271
What this trial is testing

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastomaMalignant Glioma+1 more
University of Florida 10
Testing effectiveness (Phase 2)Looking for participantsNCT06672575
What this trial is testing

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center 45
Early research (Phase 1)Study completedNCT01172964
What this trial is testing

A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaRecurrent Grade III GliomaRecurrent Grade IV Glioma+9 more
City of Hope Medical Center 15
Testing effectiveness (Phase 2)Ended earlyNCT01227434
What this trial is testing

PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma
University of California, San Francisco 23
Not applicableUnknownNCT04717999
What this trial is testing

Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
UWELL Biopharma 20
Next Page